Intelligent Bio Solutions Inc (INBS) Stock Price, Quote & News

Company Profile

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 20...

Industry: Medical Devices

Sector: Healthcare

Phone: 646 828 8258

Website: ibs.inc

Address:

135 West, 41st Street, 5th Floor, New York, United States

Guileall Mar. 15 at 1:58 PM

$INBS $SLS last opportunity to buy before 5X.. These 2 stocks are totally different but they have incredible potential!

0 · Reply

MoArif Mar. 13 at 3:25 PM

$INBS wtf is going on with this stock

0 · Reply

RaySan Mar. 13 at 3:11 PM

$INBS Adding at these bargain prices.

0 · Reply

MoArif Mar. 12 at 6:46 PM

$INBS Is this going to move?

1 · Reply

JCDollars Mar. 12 at 1:30 PM

$INBS

0 · Reply

Guileall Mar. 10 at 5:54 AM

$INBS

0 · Reply

Guileall Mar. 9 at 8:18 PM

$INBS FDA Test Analysis for end of March. Patience is the key..let see in 3 weeks where we are..

0 · Reply

Guileall Mar. 9 at 8:16 PM

$INBS 1000 shares

0 · Reply

MoArif Mar. 9 at 7:12 PM

$INBS Hello old friend, something is going on, whatever it is, keep going... <3

0 · Reply

Kzixo Mar. 9 at 6:32 PM

$INBS will something interesting happening !? Whats going on!? Will it rocket again 🤭

0 · Reply

Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry

Feb 24, 2026, 8:45 AM EST - 19 days ago

Intelligent Bio Solutions Partners with Bouygues UK, Part of Multi-Billion Dollar Global Construction Giant Bouygues Construction, for UK Drug Testing Rollout

Feb 12, 2026, 8:30 AM EST - 4 weeks ago

Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year

Feb 5, 2026, 8:30 AM EST - 5 weeks ago

Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal Year

Jan 28, 2026, 8:30 AM EST - 6 weeks ago

Intelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510(k) Submission Supporting Planned Entry into Multi-Billion Dollar U.S. Market

Jan 2, 2026, 5:00 PM EST - 2 months ago

Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Dec 31, 2025, 5:20 PM EST - 2 months ago

Intelligent Bio Solutions Announces $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Dec 31, 2025, 12:12 PM EST - 2 months ago

Intelligent Bio Stock Doubles On New Manufacturing Deal Promising Major Cost Cuts

Dec 31, 2025, 8:45 AM EST - 2 months ago

Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins

Dec 18, 2025, 8:30 AM EST - 3 months ago

Intelligent Bio Solutions Announces Strategic Partnership with Vlepis, Provider of Advanced Sensing and Wearable Patch Technologies, to Drive Innovation in Non-Invasive Screening and Consumer Health Monitoring

Dec 12, 2025, 10:30 AM EST - 3 months ago

Intelligent Bio Solutions Inc. Announces Reverse Stock Split

Nov 20, 2025, 8:30 AM EST - 4 months ago

Intelligent Bio Solutions to Participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference on December 2-3, 2025

Nov 12, 2025, 8:30 AM EST - 4 months ago

Intelligent Bio Solutions Reports Fiscal 2026 First Quarter Financial Results and Operational Highlights, Delivering Record Revenue Growth

Nov 4, 2025, 8:30 AM EST - 4 months ago

Intelligent Bio Solutions Expects to Report Record Fiscal First Quarter 2026 Revenue of Over $1 Million, an Increase of Approximately 32% Sequentially and 28% Year-Over-Year

Oct 30, 2025, 8:30 AM EDT - 4 months ago

Intelligent Bio Solutions Secures 33 New Customer Accounts in the Fiscal 2026 First Quarter, Showing Strong Year-Over-Year Growth and Increasing Total Active Accounts to 480

Oct 23, 2025, 8:30 AM EDT - 5 months ago

Intelligent Bio Solutions Secures Major UK Contract with Multinational Industrial Service Provider

Sep 26, 2025, 8:30 AM EDT - 6 months ago

Intelligent Bio Solutions Advances Preparations and Provides Updated Timeline for Anticipated FDA 510(k) Submission and Clearance

Sep 17, 2025, 8:30 AM EDT - 6 months ago

Intelligent Bio Solutions Provides Update on FDA 510(k) Clearance Process for Intelligent Fingerprinting Drug Screening System

Aug 19, 2025, 8:30 AM EDT - 7 months ago

Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July

Aug 15, 2025, 8:30 AM EDT - 7 months ago

Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies

Aug 12, 2025, 8:30 AM EDT - 7 months ago

Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025

Aug 7, 2025, 8:30 AM EDT - 7 months ago

Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum

Aug 6, 2025, 8:30 AM EDT - 7 months ago

Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch

Jul 30, 2025, 8:30 AM EDT - 8 months ago

Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator

Jul 25, 2025, 8:30 AM EDT - 8 months ago

Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds

Jul 23, 2025, 8:30 AM EDT - 8 months ago

Intelligent Bio Solutions to Strengthen FDA 510(k) Submission with New Positive Data Demonstrating Ultra-Precise Fingerprint Sweat Detection and Platform Resilience

Jul 16, 2025, 8:30 AM EDT - 8 months ago

Intelligent Bio Solutions Accelerates Global Growth with SmarTest® Patch Agreement, Reinforces U.S. Expansion Path as FDA Approval Remains a Strategic Priority

Jul 15, 2025, 8:30 AM EDT - 8 months ago

Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing

Jul 10, 2025, 8:30 AM EDT - 8 months ago

Intelligent Bio Solutions to Present PK Study Data at Association for Diagnostics and Laboratory Medicine 2025 Clinical Lab Expo

Jun 25, 2025, 8:30 AM EDT - 9 months ago

Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia

Jun 18, 2025, 8:30 AM EDT - 9 months ago

Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion

Jun 11, 2025, 8:30 AM EDT - 9 months ago

Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing

May 22, 2025, 8:30 AM EDT - 10 months ago

Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing

May 19, 2025, 8:30 AM EDT - 10 months ago

Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment

May 15, 2025, 9:00 AM EDT - 10 months ago

Intelligent Bio Solutions Accelerates Global Adoption of Fingerprint Drug Testing

May 13, 2025, 8:30 AM EDT - 10 months ago

Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements

May 6, 2025, 8:30 AM EDT - 11 months ago

Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion

Apr 22, 2025, 8:30 AM EDT - 11 months ago

Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System

Mar 28, 2025, 8:30 AM EDT - 1 year ago

Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show

Mar 27, 2025, 9:00 AM EDT - 1 year ago

Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra

Mar 26, 2025, 8:30 AM EDT - 1 year ago

Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry

Mar 25, 2025, 9:00 AM EDT - 1 year ago

Intelligent Bio Solutions' FDA Clearance Process Remains on Track for 2025 U.S. Launch

Mar 20, 2025, 8:30 AM EDT - 1 year ago

Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant

Mar 11, 2025, 8:30 AM EDT - 1 year ago

Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th

Feb 21, 2025, 4:05 PM EST - 1 year ago

Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter's Option to Purchase Additional Shares of Common Stock

Feb 20, 2025, 8:30 AM EST - 1 year ago

Intelligent Bio Solutions Inc. Announces Pricing of $2.6 Million Public Offering of Common Stock

Feb 19, 2025, 4:42 PM EST - 1 year ago

Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common Stock

Feb 13, 2025, 8:30 AM EST - 1 year ago

Intelligent Bio Solutions Announces Fiscal Q2 2025 Financial Results and Key Operational Achievements

Feb 10, 2025, 8:30 AM EST - 1 year ago

Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy

Guileall Mar. 15 at 1:58 PM

$INBS $SLS last opportunity to buy before 5X.. These 2 stocks are totally different but they have incredible potential!

0 · Reply

MoArif Mar. 13 at 3:25 PM

$INBS wtf is going on with this stock

0 · Reply

RaySan Mar. 13 at 3:11 PM

$INBS Adding at these bargain prices.

0 · Reply

MoArif Mar. 12 at 6:46 PM

$INBS Is this going to move?

1 · Reply

JCDollars Mar. 12 at 1:30 PM

$INBS

0 · Reply

Guileall Mar. 10 at 5:54 AM

$INBS

0 · Reply

Guileall Mar. 9 at 8:18 PM

$INBS FDA Test Analysis for end of March. Patience is the key..let see in 3 weeks where we are..

0 · Reply

Guileall Mar. 9 at 8:16 PM

$INBS 1000 shares

0 · Reply

MoArif Mar. 9 at 7:12 PM

$INBS Hello old friend, something is going on, whatever it is, keep going... <3

0 · Reply

Kzixo Mar. 9 at 6:32 PM

$INBS will something interesting happening !? Whats going on!? Will it rocket again 🤭

0 · Reply

Stock_Catcher Mar. 5 at 3:07 AM

Treasure Thursday Watchlist Pt 10 $AEHL $GITS $MNTS $INBS $NVTS Another Day of Action Tomorrow

1 · Reply

Meri7 Mar. 4 at 9:26 AM

$INBS was that all? Is it over? Very good news and just a small increase in price.

0 · Reply

focafoca99 Mar. 1 at 10:36 PM

$INBS momentum building — shipment milestone + 48% YoY revenue growth + UK partnership. Traders clearly liking the execution.

0 · Reply

Touji93 Feb. 28 at 2:27 AM

$INBS There's been a steady stream of verbal declines, but today we've seen a small rise, so we've got a bunch of stupid people coming in again. Stupid marches always keep me entertained 🤣

0 · Reply

JAMBAR Feb. 28 at 12:12 AM

$INBS Key Information & Recent Developments: Technology: The Intelligent Fingerprinting Drug Testing Solution detects, opiates, cocaine, methamphetamine, and cannabis, providing a hygienic alternative to urine/saliva tests. Market Position: Focused on high-risk industries for on-site, rapid drug screening, with plans to expand its US presence after 2024 FDA 510(k) submissions. Stock Info: Traded on NASDAQ as INBS. As of February 27, 2026, the stock was trading around $4.50, with a 52-week range of $3.72 to $25.00. Financials: The company, formerly GBS Inc., was incorporated in 2016 and is headquartered in New York. Operational Focus: Beyond drug testing, they are developing a saliva glucose biosensor platform. Intelligent Bio Solutions Inc. Intelligent Bio Solutions Inc. +6 Intelligent Bio Solutions Inc. (INBS) - Yahoo Finance Feb 25, 2026 — Bid 3.4300 x 200. Ask 5.2200 x 200. 52 Week Range 3.7000 - 25.0000. Volume 283,550. Avg. Volume 2,428,228. Market Cap (intraday) 7... Yahoo Finance

0 · Reply

MoArif Feb. 27 at 9:07 PM

$INBS Will this ever go to $15-25 like it did most of 2025 realistically?

1 · Reply

Dr_Smith Feb. 27 at 6:31 PM

$INBS Can anyone speak intelligently about this stock? Why is it suddenly up?

2 · Reply

6GodEnergy Feb. 27 at 6:06 PM

*@SqueezeSharkie is operating at a level that clearly sets him apart from most traders in this space. If you’re serious about improving your decision-making and refining your edge, he’s worth following. There’s no cost, just consistent insights backed by performance. $INBS $AGIG $JCSE $FMFC *^ on close watch.

0 · Reply

SmartMoneyTradez Feb. 27 at 4:16 PM

$INBS Low float next in line but needs volume. Showing potential of a squeeze like $ENSC $XWEL . Also watching $JCSE and $HCWC

0 · Reply

topstockalerts Feb. 27 at 3:59 PM

$INBS Impressive strength showing today. Price refuses to pull back. Buyers remain aggressive 🔥.

0 · Reply

JAMBAR Feb. 27 at 3:23 PM

$INBS WHEELS UP!

0 · Reply

Lucky72 Feb. 26 at 1:28 AM

$INBS 8 K

0 · Reply

Market Cap	6.42M
Revenue (ttm)	3.05M
Net Income (ttm)	-10.57M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	1.14
Profit Margin	-346.56%
Debt to Equity Ratio	0.00

Volume	53,500
Avg Vol	2,959,866
Day's Range	N/A - N/A
Shares Out	1.60M
Stochastic %K	21%
Beta	4.58
Analysts	Sell
Price Target	$120.00